Videos

Featured

View from the Thoraxcenter: ESC Congress 25 Preview

Joost Daemen, Nicolas M Van Mieghem

Watch time: 36m 33s
ESC 25: TRISCEND II Trial: TTVR Outcomes by Baseline TR Severity

Philipp Lurz

Watch time: 4m 15s
TTE and TEE in the New TAVR Era with Dr Victoria Delgado

Victoria Delgado

Watch time: 16m 27s
NY Valves 25: The Tri-QOL Study

Watch time: 5m 58s
EuroPCR 25: The TRICURE EU Study

Julien Dreyfus

Watch time: 4m 9s
SCAI 25: Insights from the TRITAVI Registry

Francesco Pelliccia

Watch time: 11m 23s
NY Valves 25: Lifetime Management in TAVR Patients

Tanush Gupta

Watch time: 12m 2s
TCT Middle East 25: Minimally Invasive Surgery

Rania Hammami, Uthman Aluthman

Watch time: 5m 1s
EuroPCR 25: BIOADAPTOR RCT 3Y Outcomes

Shigeru Saito

Watch time: 2m 29s
EHRA 25: The SwissTAVI Registry

Watch time: 3m 9s

Broadcast

Intervention
Transcatheter Interventions Online 2025 - Day One

Nicolas M Van Mieghem, David Hildick-Smith, Roxana Mehran, et al

Trending

Broadcast

Intervention
Advancing Tricuspid Valve Replacement: Real-World Outcomes and Best…

Raj Makkar, Rebecca T Hahn, Fabien Praz, et al

ESC 25 Discussion: 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease

Harriette Van Spall, Michael Andrew Borger

Watch time: 14m 30s

Ali Vazir, Volker Rudolph, Sam Dawkins, et al

Watch time: 1h 1m 19s (5 videos)

Ole De Backer, Angela McInerney

Watch time: 21m 57s (4 videos)

Christopher M Cook, Pilar Jimenez-Quevedo, Clare Appleby, et al

Watch time: 1h 47s (6 videos)

Alison Duncan,

Watch time: 15h 55m 22s (44 videos)

London Valves 25: AltaValve EFS: Broad Applicability at One-Year Outcomes

Vlasis Ninios

Watch time: 4m 44s

Joost Daemen, Nicolas M Van Mieghem

Watch time: 5h 48m 39s (30 videos)
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini

Watch time: 8m 1s

Events

Filter by

NVM Cardiology Meeting Reflections: AHA 25 Preview

Nicolas M Van Mieghem

Watch time: 14m 12s
London Valves 25: AltaValve EFS: Broad Applicability at One-Year Outcomes

Vlasis Ninios

Watch time: 4m 44s
AHA 25: TUXEDO-2: Ticagrelor vs Prasugrel in Diabetic PCI

Sripal Bangalore, Harriette Van Spall

Watch time: 17m 17s
NVM Cardiology Meeting Reflections: AHA 25 Preview

Nicolas M Van Mieghem

Watch time: 9m 56s
TCT 25: Seven-Year Follow-up of the PARTNER 3 Trial

Michael J Mack

Watch time: 10m 32s
TCT 25: ENCIRCLE Trial Insights with Dr Daniels & Dr Hamid

Nadira Hamid, David V Daniels

Watch time: 28m 2s
TCT 25 Structural Interventions Highlights

Nadira Hamid, Rahul P Sharma

Watch time: 21m 50s
2 Trials That Will Change My Practice with Prof Rasha Al-Lamee

Rasha Al-Lamee

Watch time: 2m 12s
TCT 2025: 10-Year Mortality in NOBLE: PCI vs CABG for Left Main Disease

Evald Høj Christiansen

Watch time: 4m 10s
TCT 2025: Short-CUT: Lithotripsy Vs Cutting Balloon for CAD

Suzanne J Baron

Watch time: 6m 55s

Latest

Filter by

CRT 23: The OPTIMAL Randomized Controlled Trial

José M de la Torre Hernández

Watch time: 6m 1s

Prakriti Gaba, Joost Daemen, Bernardo Cortese, et al

Watch time: 22m 47s (4 videos)

Paul Sorajja, Ralph Stephan von Bardeleben, , et al

Watch time: 16m 15s (4 videos)
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 33m 36s
ACC 23 Interventional Late-breaking Highlights

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 16m 22s

Marco Valgimigli, Eliano Navarese, Pascal Vranckx

Watch time: 1h 48m 18s (11 videos)
ACC.23 Late-Breaker Discussion: The BIOVASC Trial

Harriette Van Spall, Roberto Diletti

Watch time: 12m 7s
ACC 23: The Evolut Low Risk Trial

John Forrest

Watch time: 3m 46s